RxDoctor Payments DataLook up a doctor →

Kirk Ridley, MD

Family Medicine · Belton, MONPI 1922093954

Payments from drug & device makers

$17,677in general payments, 2019–2025

Across 944 payments — averaging $18.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$3K
  • AbbVie$3K
  • Lilly USA, LLC$1K
  • Abbott$1K
  • Pfizer$1K
  • Boehringer Ingelheim$929
  • plus $8K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca84$2,644
AbbVie(2 entities)138$2,602
Lilly USA, LLC80$1,318
Abbott43$1,281
Pfizer92$1,136
Boehringer Ingelheim58$929
Novo Nordisk61$896
GSK54$872
Amgen(2 entities)31$728
Johnson & Johnson26$484
Bayer22$451
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC29$408
Merck23$353
Otsuka America Pharmaceutical, Inc.19$316
Biohaven Pharmaceuticals, Inc.8$229
Takeda Pharmaceuticals U.S.A., Inc.13$203
Astellas Pharma US Inc11$188
Novartis12$168
Biohaven Pharmaceutical Holding Company Ltd.11$166
Exact Sciences11$164
Dexcom, Inc.10$164
Upsher-smith Laboratories LLC8$153
Hologic Sales And Service, LLC2$139
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)7$126
Kowa Pharmaceuticals America, Inc.9$116
Esperion Therapeutics, Inc.6$96
Vertex4$88
Adlon Therapeutics L.p.6$78
Lundbeck LLC4$76
Ardelyx, Inc.3$71
Eisai Inc.5$69
Sumitomo Pharma America, Inc.3$67
Amarin Pharma, Inc.4$60
Saluda Medical Americas, Inc.3$60
Boston Scientific2$48
Ironwood Pharmaceuticals, Inc3$45
Phathom Pharmaceuticals, Inc.3$44
UCB, Inc.2$43
Almatica Pharma LLC2$42
Nevro Corp.2$40
Teva Pharmaceuticals USA, Inc.3$39
Shire North American Group Inc2$39
Mylan Specialty L.p.3$39
E.r. Squibb & Sons, L.L.C.2$39
Angiodynamics, Inc.1$38
Neurelis, Inc.1$32
Vanda Pharmaceuticals Inc.1$32
Ironshore Pharmaceuticals Inc.2$30
Sunovion Pharmaceuticals Inc.2$27
Regeneron Healthcare Solutions, Inc.1$26
Genentech USA, Inc.2$23
IBSA Pharma Inc.1$20
Shield Therapeutics Inc1$18
Sanofi1$17
Corium, LLC1$17
Idorsia Pharmaceuticals US Inc1$17
Sanofi-aventis U.S. LLC1$15
Corcept Therapeutics1$14
Assertio Therapeutics, Inc.1$14
Tolmar, Inc.1$13

How this compares

$17,677 in reported general payments places this provider in the 95th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri →

Medicare billing

Part B allowed, 2024
$67,335
Medicare patients
207
Services billed
745

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Belton

See the full list for Missouri →

Where these figures come from

Is this you, or does something look wrong? →